Evidence map›Paper›PMID 36582604›Full record

ArticleRegenerative therapy2023

Controlled release of canine MSC-derived extracellular vesicles by cationized gelatin hydrogels.

Karin Yoshizaki, Hidetaka Nishida, Yasuhiko Tabata, Jun-Ichiro Jo, Ikuhiko Nakase, Hideo Akiyoshi

Open access · goldAbstract read
In one paragraph

Article in Regenerative therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Kidney-Derived ECM Hydrogels as Cell Delivery Devices.ACS applied materials & interfaces · 2025
    Article
  4. Article
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Karin YoshizakiDepartment of Veterinary Surgery, Graduate School of Life and Veterinary Science, Osaka Metropolitan University, Izumisano, Osaka, Japan.
Hidetaka NishidaDepartment of Veterinary Surgery, Graduate School of Life and Veterinary Science, Osaka Metropolitan University, Izumisano, Osaka, Japan.
Yasuhiko TabataLaboratory of Biomaterials, Department of Regeneration Science and Engineering Institute for Life and Medical Sciences, Kyoto University, Kyoto, Kyoto, Japan.
Jun-Ichiro JoLaboratory of Biomaterials, Department of Regeneration Science and Engineering Institute for Life and Medical Sciences, Kyoto University, Kyoto, Kyoto, Japan.
Ikuhiko NakaseGraduate School of Science, Osaka Metropolitan University, Sakai, Osaka, Japan.
Hideo AkiyoshiDepartment of Veterinary Surgery, Graduate School of Life and Veterinary Science, Osaka Metropolitan University, Izumisano, Osaka, Japan.
Osaka Metropolitan University · JPKyoto University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Canine mesenchymal stem cell (MSC)-derived extracellular vesicles (EVs) have emerged as a promising form of regenerative therapy. Therapeutic application of EVs remains difficult due to the short half-life of EVs Methods: Canine MSCs were isolated from bone marrow. MSC-derived EVs were isolated from the culture supernatant by ultracentrifugation. Gelatin was mixed with ethylene diamine anhydrate to cationized. Distinct cross-linked cationized gelatin hydrogels were created by thermal dehydration. Hydrogels were implanted into the back subcutis of mice in order to evaluate the degradation profiles. Hydrogels with collagenase were incubated at 37 °C Results: The cationized gelatin hydrogels suppressed EV release in PBS. More than 60% of immobilized EVs are not released from the hydrogels. The cationized hydrogels released EVs in a sustainable manner and prolonged the retention time of EVs depending on the intensity of cross-linking after degradation by collagenase. The expression of IL-1β in LPS-stimulated BV-2 cells was lower in EVs released from the hydrogels than in controls. Conclusions: Our results indicate that the controlled release of EVs can be achieved by cationized gelatin hydrogels. The released EVs experimentally confirmed to be effective in reducing proinflammatory response. The cationized gelatin hydrogels appear to be useful biomaterials for releasing canine MSC-derived EVs for regenerative therapy.

Indexed as

CanineControlled releaseExtracellular vesicleGelatinHydrogelMesenchymal stem cell

Identifiers

PMID36582604
PMCPMC9761439
OpenAlexW4310974105

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.